Mayo Clinic researchers clarify chemo resistance, and perhaps a new therapy

ROCHESTER, Minn. ? Mayo Clinic scientists have identified a specific protein implicated in drug resistance, as well as a possible therapeutic tool. Their work appears in the EMBO Journal. The team led by Haojie Huang, Ph.D., a Mayo Clinic tumor biologist within Mayo Clinic?s Center for Biomedical Discovery identified the role of FOXO1 in chemotherapy [...]
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news